mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.1 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.1 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.2 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |